Wuxi Taxus Pharmaceutical

Wuxi Taxus Pharmaceutical Co., Ltd. is a specialized pharmaceutical company focused on the research, development, and large-scale production of taxane-based anti-cancer agents. As a subsidiary of the HOdo Group, the company leverages one of the world's largest Taxus chinensis plantations to ensure a sustainable supply of raw materials for Paclitaxel and its derivatives. Their product portfolio includes high-purity APIs such as Paclitaxel, Docetaxel, and Cabazitaxel, as well as key intermediates like 10-DAB III. The company operates GMP-compliant manufacturing facilities and provides contract manufacturing services for oncology therapeutics. Wuxi Taxus Pharmaceutical serves a global market, supplying essential oncology ingredients to pharmaceutical manufacturers worldwide. They are recognized for their expertise in plant extraction and semi-synthetic chemical processes.